HIVMA is encouraged that funding for key HIV programs has increased in the U.S. House of Representatives Appropriations Committee’s funding bill for Labor, Health and Human Services programs for fiscal year 2023.
HIVMA is encouraged that funding for key HIV programs has increased in the U.S. House of Representatives Appropriations Committee’s funding bill for Labor, Health and Human Services programs for fiscal year 2023.
Increasing access to monkeypox testing and expanding vaccination against infection to people at high risk are needed and welcome steps in efforts to control spread and minimize symptoms.
IDSA and HIVMA condemn the U.S. Supreme Court decision overturning Roe v. Wade that sanctions government interference in patient autonomy and care and threatens the sanctity of the provider-patient relationship.
People who may be most in need of antiviral treatment for COVID-19 may not be receiving it because of where they live, according to a recent report from the U.S. Centers for Disease Control and Prevention.
IDSA and HIVMA echo the concern expressed by UNAIDS about the use of racist and homophobic language regarding the current monkeypox outbreak.
In his budget plan for fiscal year 2023, President Joe Biden calls for important investments to grow the Ending the HIV Epidemic initiative and to create a National PrEP Program that will dramatically increase access to PrEP and reach many more of the 1.2 million people who could benefit from it.
HIVMA applauds President Biden for calling for the creation of a national PrEP program with an investment of $9.8 billion in mandatory funding over 10 years in his fiscal year 2023 budget proposal.
HIVMA is deeply concerned by the harm that the “Parental Rights in Education” bill passed today by the Florida legislature will have on the health and quality of life of LGBTQ youth and families if signed into law.
IDSA and HIVMA strongly urge Texas Gov. Greg Abbott to stop government interference in the patient-health care provider relationship by withdrawing the order released last week that classifies medical treatment provided to transgender youth as “child abuse.”
IDSA and HIVMA recommendations for states and local jurisdictions to consider in determining the allocation of the limited supplies of COVID-19 antiviral pills.
On this World AIDS Day, HIVMA welcomes the release of the Biden-Harris Administration’s 2022 National HIV/AIDS Strategy, which will provide an important road map for ending HIV as an epidemic in the United States.
IDSA and HIVMA applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), H.R. 5602, and its inclusion in an Oct. 26 Energy and Commerce Health Subcommittee hearing.